• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 in patients with rheumatic diseases: what is the real mortality risk?

作者信息

Marques Claudia, Pinheiro Marcelo M, Reis Neto Edgard Torres, Dantas Andrea Tavares, Ribeiro Francinne Machado, Melo Ana Karla G

机构信息

Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil

Hospital São Paulo, Universidade Federal de São Paulo, São Paulo, Brazil.

出版信息

Ann Rheum Dis. 2022 Aug;81(8):e134. doi: 10.1136/annrheumdis-2020-218388. Epub 2020 Jul 13.

DOI:10.1136/annrheumdis-2020-218388
PMID:32660978
Abstract
摘要

相似文献

1
COVID-19 in patients with rheumatic diseases: what is the real mortality risk?风湿性疾病患者中的新型冠状病毒肺炎：实际死亡风险是多少？
Ann Rheum Dis. 2022 Aug;81(8):e134. doi: 10.1136/annrheumdis-2020-218388. Epub 2020 Jul 13.
2
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases.意大利风湿性自身免疫性系统性疾病患者中的新冠肺炎情况。
Ann Rheum Dis. 2023 Sep;82(9):e211. doi: 10.1136/annrheumdis-2020-219113. Epub 2020 Oct 14.
3
Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.COVID-19 大流行期间，自身免疫性风湿性疾病患者的心血管健康状况恶化。
Clin Rheumatol. 2023 Oct;42(10):2677-2690. doi: 10.1007/s10067-022-06486-4. Epub 2023 Jan 11.
4
Risk of lymphoma in autoimmune rheumatic conditions.自身免疫性风湿性疾病患者患淋巴瘤的风险。
Arch Intern Med. 2006 Jun 12;166(11):1233-4; author reply 1234. doi: 10.1001/archinte.166.11.1233-b.
5
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.COVID-19 与风湿性自身免疫性系统性疾病：一项大型意大利患者系列报告。
Clin Rheumatol. 2020 Nov;39(11):3195-3204. doi: 10.1007/s10067-020-05334-7. Epub 2020 Aug 27.
6
Correspondence to 'Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases'.致《慢性炎症和自身免疫性风湿性疾病患者中经医院PCR确诊的COVID-19病例的患病率》
Ann Rheum Dis. 2022 Dec;81(12):e243. doi: 10.1136/annrheumdis-2020-219000. Epub 2020 Sep 25.
7
Trends in mortality in patients with systemic autoimmune rheumatic diseases (SARD) during the COVID-19 pandemic in Mexico.墨西哥 COVID-19 大流行期间系统性自身免疫性风湿病（SARD）患者的死亡率趋势。
Rheumatol Int. 2023 Sep;43(9):1611-1619. doi: 10.1007/s00296-023-05371-w. Epub 2023 Jun 22.
8
Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia.马来西亚砂拉越州风湿性疾病患者合并新型冠状病毒肺炎感染的临床特征
Ann Rheum Dis. 2022 Aug;81(8):e148. doi: 10.1136/annrheumdis-2020-218425. Epub 2020 Jul 24.
9
Autoimmune rheumatic diseases and the heart.自身免疫性风湿疾病与心脏
Hosp Med. 1999 Feb;60(2):95-9. doi: 10.12968/hosp.1999.60.2.1813.
10
Pancreatic disease in the autoimmune rheumatic disorders.自身免疫性风湿性疾病中的胰腺疾病
Semin Arthritis Rheum. 1989 Dec;19(3):158-65. doi: 10.1016/0049-0172(89)90028-0.

引用本文的文献

1
COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.沙特阿拉伯东部省份风湿性疾病患者的 COVID-19 。
J Med Life. 2023 Jun;16(6):873-882. doi: 10.25122/jml-2023-0037.
2
Systemic lupus erythematosus nephritis and COVID-19 disease.系统性红斑狼疮肾炎与 COVID-19 疾病。
Clin Rheumatol. 2023 Sep;42(9):2335-2340. doi: 10.1007/s10067-023-06634-4. Epub 2023 May 17.
3
How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study.
患有免疫介导性风湿病的患者如何应对巴西 COVID-19 大流行的开始？COnVIDa 研究的结果。
J Clin Rheumatol. 2024 Jan 1;30(1):e29-e33. doi: 10.1097/RHU.0000000000001882. Epub 2022 Jun 14.
4
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study.系统性硬化症患者 COVID-19 的严重程度和死亡率：巴西多中心研究。
Semin Arthritis Rheum. 2022 Aug;55:151987. doi: 10.1016/j.semarthrit.2022.151987. Epub 2022 Feb 25.
5
COVID GEAS: COVID-19 National Survey in Patients With Systemic Autoimmune Diseases.COVID GEAS：系统性自身免疫性疾病患者的COVID-19全国调查。
Front Med (Lausanne). 2022 Jan 27;8:808608. doi: 10.3389/fmed.2021.808608. eCollection 2021.
6
Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.慢性使用羟氯喹并未在巴西的一大群风湿疾病患者中预防 COVID-19。
Adv Rheumatol. 2021 Oct 7;61(1):60. doi: 10.1186/s42358-021-00217-0.
7
Poor Prognosis of COVID-19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross-Sectional Population Study Of 252 119 Patients.狼疮性 COVID-19 急性呼吸窘迫综合征的预后不良：252119 例患者的全国性横断面人群研究
ACR Open Rheumatol. 2021 Nov;3(11):804-811. doi: 10.1002/acr2.11329. Epub 2021 Aug 23.
8
Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.能否仅使用人口统计学和合并症数据来预测欧洲队列中的 COVID-19 死亡率，超过基于年龄的预测：一项外部验证研究。
PLoS One. 2021 Apr 15;16(4):e0249920. doi: 10.1371/journal.pone.0249920. eCollection 2021.
9
SARS-CoV-2 and Systemic Lupus Erythematosus.新型冠状病毒与系统性红斑狼疮。
Curr Rheumatol Rep. 2021 Jan 28;23(2):8. doi: 10.1007/s11926-020-00973-w.
10
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.高水平免疫抑制与风湿性疾病和 COVID-19 住院患者的不良结局相关：ReumaCoV Brasil 登记处的初步结果。
RMD Open. 2021 Jan;7(1). doi: 10.1136/rmdopen-2020-001461.